Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest update is out from Genscript Biotech ( (HK:1548) ).
Genscript Biotech Corporation has announced the establishment of a sub-committee on data security and geopolitical resilience as part of its Risk Management and ESG Committee, effective February 5, 2025. This strategic move is aimed at bolstering the company’s oversight on critical risk areas including geopolitical, data security, cyber security, and cross-border intellectual property risks, which may enhance its operational robustness and market positioning.
More about Genscript Biotech
Genscript Biotech Corporation, incorporated in the Cayman Islands, operates in the biotechnology industry. The company is listed on The Stock Exchange of Hong Kong Limited and focuses on risk management, data security, and geopolitical resilience, among other areas.
YTD Price Performance: 9.06%
Average Trading Volume: 6,262
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $2.96B
Learn more about 1548 stock on TipRanks’ Stock Analysis page.
